PCSK9 inhibition: the dawn of a new age in cholesterol lowering?
Crossref DOI link: https://doi.org/10.1007/s00125-016-4178-y
Published Online: 2016-12-26
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Preiss, David
Mafham, Marion
Funding for this research was provided by:
University of Oxford
License valid from 2016-12-26